In contrast, consistent with previous studies, pErk expression in K-ras/COX-2−/− mice was downregulated compared with that in K-ras mice, which suggests that COX-2 deletion reduced PGE2 levels, blocked the MAPK pathway, and subsequently inhibited tumor proliferation in K-ras mice. The gene discussed is PTGS2; the disease is neoplasm.